Be the first to like this
Presentation: Implications of the Affordable Care Act to the Pharmaceutical Industry
Presented by: Kirsten Axelsen, Vice President, Worldwide Policy, Pfizer
Overview of what the coverage expansion and payment reforms in the Affordable Care Act mean for access to medicine and for new treatments and cures. Issues for patients and policy makers to consider as the healthcare system increasingly relies on medicine to manage conditions, avoid disease and save on healthcare system costs.